Dean McMillan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Dean McMillan has a total of 297 co-authors. Here are the top co-authors by number of shared publications:
- Simon Gilbody
Department of Health Sciences, University of York, York, UK
27 shared publications - Carolyn Anne Chew-Graham
School of Medicine, Keele University, Keele, Staffordshire, UK
14 shared publications - Della Bailey
Department of Health Sciences, University of York
12 shared publications - Catherine Hewitt
Department of Health Sciences, University of York
11 shared publications - David Ekers
University of York Department of Health Sciences
11 shared publications - Karina Lovell
Division of Nursing, Midwifery and Social Work, University of Manchester, Manchester M13 9PL, UK
11 shared publications
Latest Publications
- Open Access
Behavioural activation for low mood and anxiety in male frontline NHS workers (BALM): a pre-post intervention study
Objectives: To evaluate the impact and acceptability of a tailored, gender-responsive behavioural activation intervention for improving depression and anxiety in male NHS frontline workers. Design: Pre-post intervention study. Setting: Three National Health Service (NHS) organisations in the North of England. Participants: Forty-five men aged ≥ 18 years working in a frontline NHS role scoring in the subclinical range (5-14) on the PHQ-9 (depression) and/or the GAD-7 (anxiety) at baseline. Interventions: A tailored Behavioural Activation treatment programme consisting of up to eight telephone support sessions over a period of 4–6 weeks, accompanied by a Behavioural Activation self-help manual. Main outcome measures: Self-reported symptom severity of depression, assessed by PHQ-9, and anxiety, assessed by GAD-7, at baseline and 4- and 6-months. Acceptability from the perspectives of male study participants and coaches who delivered the intervention was assessed in a nested qualitative study using the theoretical framework of acceptability (TFA). Results: PHQ-9 and GAD-7 scores decreased from baseline to 4 months on both the PHQ-9 and GAD-7. While scores increased from 4 months to 6 months, the 6-month scores remained below those of the baseline scores. Acceptability of the intervention was high across all constructs of the TFA. The practical and action-oriented strategies of the intervention, and the confidential, flexible, convenient mode of delivery, worked to support men’s engagement with the intervention. Conclusions: Delivery of a tailored, gender-responsive Behavioural Activation intervention was appealing to, and beneficial for, men working in frontline NHS roles with less severe depression and anxiety. The BALM intervention offers promise as a tailored workplace mental health programme that is aligned with men’s needs and preferences and can help overcome a reticence to engage with mental health support in NHS staff and beyond. Trial registration: ISRCTN 48636092 Strengths and limitations of this study: This is the first study to evaluate the impact and acceptability of a Behavioural Activation intervention for improving depression and anxiety in men using a gendered lens, contributing novel findings of relevance wider than the study context. The use of the TFA to inform data collection and analysis enabled a theoretically informed, systematic evaluation of the acceptability of the intervention. Rich data were gathered from qualitative interviews with a large sample of male participants and coaches who supported intervention delivery, including participant non-completers. Participants were a self-selecting sample of men who may have been particularly motivated to take part in the intervention. It is possible their views on the acceptability of the Behavioural Activation (BALM) intervention are more positive than the wider population of male NHS staff. Our sample also lacked ethnocultural diversity and representation of some NHS staff groups, particularly ancillary roles, that limits the transferability of the findings. The quasi-experimental research design is not sufficiently reliable to make causal inferences.
Open AccessBehavioural activation for low mood and anxiety in male frontline NHS workers (BALM): a pre-post intervention study
Objectives: To evaluate the impact and acceptability of a tailored, gender-responsive behavioural activation intervention for improving depression and anxiety in male NHS frontline workers. Design: Pre-post intervention study. Setting: Three National Health Service (NHS) organisations in the North of England. Participants: Forty-five men aged ≥ 18 years working in a frontline NHS role scoring in the subclinical range (5-14) on the PHQ-9 (depression) and/or the GAD-7 (anxiety) at baseline. Interventions: A tailored Behavioural Activation treatment programme consisting of up to eight telephone support sessions over a period of 4–6 weeks, accompanied by a Behavioural Activation self-help manual. Main outcome measures: Self-reported symptom severity of depression, assessed by PHQ-9, and anxiety, assessed by GAD-7, at baseline and 4- and 6-months. Acceptability from the perspectives of male study participants and coaches who delivered the intervention was assessed in a nested qualitative study using the theoretical framework of acceptability (TFA). Results: PHQ-9 and GAD-7 scores decreased from baseline to 4 months on both the PHQ-9 and GAD-7. While scores increased from 4 months to 6 months, the 6-month scores remained below those of the baseline scores. Acceptability of the intervention was high across all constructs of the TFA. The practical and action-oriented strategies of the intervention, and the confidential, flexible, convenient mode of delivery, worked to support men’s engagement with the intervention. Conclusions: Delivery of a tailored, gender-responsive Behavioural Activation intervention was appealing to, and beneficial for, men working in frontline NHS roles with less severe depression and anxiety. The BALM intervention offers promise as a tailored workplace mental health programme that is aligned with men’s needs and preferences and can help overcome a reticence to engage with mental health support in NHS staff and beyond. Trial registration: ISRCTN 48636092 Strengths and limitations of this study: This is the first study to evaluate the impact and acceptability of a Behavioural Activation intervention for improving depression and anxiety in men using a gendered lens, contributing novel findings of relevance wider than the study context. The use of the TFA to inform data collection and analysis enabled a theoretically informed, systematic evaluation of the acceptability of the intervention. Rich data were gathered from qualitative interviews with a large sample of male participants and coaches who supported intervention delivery, including participant non-completers. Participants were a self-selecting sample of men who may have been particularly motivated to take part in the intervention. It is possible their views on the acceptability of the Behavioural Activation (BALM) intervention are more positive than the wider population of male NHS staff. Our sample also lacked ethnocultural diversity and representation of some NHS staff groups, particularly ancillary roles, that limits the transferability of the findings. The quasi-experimental research design is not sufficiently reliable to make causal inferences.
- Open Access
- 14 April 2025
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 228 (2) , 150-163
Dog-assisted interventions for children and adults with mental health or neurodevelopmental conditions: systematic review
Background: Dog-assisted interventions (DAIs) to improve health-related outcomes for people with mental health or neurodevelopmental conditions are becoming increasingly popular. However, DAIs are not based on robust scientific evidence. Aims: To determine the effectiveness of DAIs for children and adults with mental health or neurodevelopmental conditions, assess how well randomised controlled trials (RCTs) are reported, and examine the use of terminology to classify DAIs. Methods: A systematic search was conducted in Embase, PsycINFO, PubMed, CINAHL, Web of Science and the Cochrane Library. RCTs were grouped by commonly reported outcomes and described narratively with forest plots reporting standardised mean differences and 95% confidence intervals without a pooled estimate. The quality of reporting of RCTs and DAIs was evaluated by assessing adherence to CONSORT and the Template for Intervention Description and Replication (TIDieR) guidelines. Suitability of use of terminology was assessed by mapping terms to the intervention content described. Results: Thirty-three papers were included, reporting 29 RCTs (with five assessed as overall high quality); a positive impact of DAIs was found by 57% (8/14) for social skills and/or behaviour, 50% (5/10) for symptom frequency and/or severity, 43% (6/14) for depression and 33% (2/6) for agitation. The mean proportion of adherence to the CONSORT statement was 48.6%. The TIDieR checklist also indicated considerable variability in intervention reporting. Most DAIs were assessed as having clear alignment for terminology, but improvement in reporting information is still required. Conclusions: DAIs may show promise for improving mental health and behavioural outcomes for those with mental health or neurodevelopmental conditions, particularly for conditions requiring social skill support. However, the quality of reporting requires improvement.
- 14 April 2025
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 228 (2) , 150-163
Open AccessDog-assisted interventions for children and adults with mental health or neurodevelopmental conditions: systematic review
Background: Dog-assisted interventions (DAIs) to improve health-related outcomes for people with mental health or neurodevelopmental conditions are becoming increasingly popular. However, DAIs are not based on robust scientific evidence. Aims: To determine the effectiveness of DAIs for children and adults with mental health or neurodevelopmental conditions, assess how well randomised controlled trials (RCTs) are reported, and examine the use of terminology to classify DAIs. Methods: A systematic search was conducted in Embase, PsycINFO, PubMed, CINAHL, Web of Science and the Cochrane Library. RCTs were grouped by commonly reported outcomes and described narratively with forest plots reporting standardised mean differences and 95% confidence intervals without a pooled estimate. The quality of reporting of RCTs and DAIs was evaluated by assessing adherence to CONSORT and the Template for Intervention Description and Replication (TIDieR) guidelines. Suitability of use of terminology was assessed by mapping terms to the intervention content described. Results: Thirty-three papers were included, reporting 29 RCTs (with five assessed as overall high quality); a positive impact of DAIs was found by 57% (8/14) for social skills and/or behaviour, 50% (5/10) for symptom frequency and/or severity, 43% (6/14) for depression and 33% (2/6) for agitation. The mean proportion of adherence to the CONSORT statement was 48.6%. The TIDieR checklist also indicated considerable variability in intervention reporting. Most DAIs were assessed as having clear alignment for terminology, but improvement in reporting information is still required. Conclusions: DAIs may show promise for improving mental health and behavioural outcomes for those with mental health or neurodevelopmental conditions, particularly for conditions requiring social skill support. However, the quality of reporting requires improvement.
- Open Access
Protocol for a qualitative study exploring older adults’ experience of mental health and wellbeing in work-related later life transitions
Later life transitions occur in the later years of life and can cause significant disruption to a person’s usual daily routine and lifestyle. Transitions that are specifically related to work, such as retirement, can cause sudden changes to an individual’s financial, social and psychological environment and for some, may negatively impact on mental health and wellbeing. This protocol outlines a qualitative study to explore the experiences of adults who have experienced a negative impact on their mental health or wellbeing due to a work-related transition in later life. Semi-structed interviews will be completed with people aged 50 and over to gain a deeper understanding of 1) the mental health and wellbeing of people undertaking later life transitions; 2) the context surrounding the transitions (such as due to ill-health or redundancy); and 3) the types of support they received or may have benefitted from. Research in this area is scarce and this study will help us to better understand the experience of those who have encountered such difficulties to help develop appropriate interventions and support in this area.
Open AccessProtocol for a qualitative study exploring older adults’ experience of mental health and wellbeing in work-related later life transitions
Later life transitions occur in the later years of life and can cause significant disruption to a person’s usual daily routine and lifestyle. Transitions that are specifically related to work, such as retirement, can cause sudden changes to an individual’s financial, social and psychological environment and for some, may negatively impact on mental health and wellbeing. This protocol outlines a qualitative study to explore the experiences of adults who have experienced a negative impact on their mental health or wellbeing due to a work-related transition in later life. Semi-structed interviews will be completed with people aged 50 and over to gain a deeper understanding of 1) the mental health and wellbeing of people undertaking later life transitions; 2) the context surrounding the transitions (such as due to ill-health or redundancy); and 3) the types of support they received or may have benefitted from. Research in this area is scarce and this study will help us to better understand the experience of those who have encountered such difficulties to help develop appropriate interventions and support in this area.
- Open Access
- 28 October 2024
- Published by BMJ in BMJ Mental Health
- Vol. 27 (1) , e301226
Development and validation of a prognostic model to predict relapse in adults with remitted depression in primary care: secondary analysis of pooled individual participant data from multiple studies
Background Relapse of depression is common and contributes to the overall associated morbidity and burden. We lack evidence-based tools to estimate an individual’s risk of relapse after treatment in primary care, which may help us more effectively target relapse prevention. Objective The objective was to develop and validate a prognostic model to predict risk of relapse of depression in primary care. Methods Multilevel logistic regression models were developed, using individual participant data from seven primary care-based studies (n=1244), to predict relapse of depression. The model was internally validated using bootstrapping, and generalisability was explored using internal–external cross-validation. Findings Residual depressive symptoms (OR: 1.13 (95% CI: 1.07 to 1.20), pConclusions We could not predict risk of depression relapse with sufficient accuracy in primary care data, using routinely recorded measures. Relationship status warrants further research to explore its role as a prognostic factor for relapse. Clinical implications Until we can accurately stratify patients according to risk of relapse, a universal approach to relapse prevention may be most beneficial, either during acute-phase treatment or post remission. Where possible, this could be guided by the presence or absence of known prognostic factors (eg, residual depressive symptoms) and targeted towards these. Trial registration number NCT04666662.
- 28 October 2024
- Published by BMJ in BMJ Mental Health
- Vol. 27 (1) , e301226
Open AccessDevelopment and validation of a prognostic model to predict relapse in adults with remitted depression in primary care: secondary analysis of pooled individual participant data from multiple studies
Background Relapse of depression is common and contributes to the overall associated morbidity and burden. We lack evidence-based tools to estimate an individual’s risk of relapse after treatment in primary care, which may help us more effectively target relapse prevention. Objective The objective was to develop and validate a prognostic model to predict risk of relapse of depression in primary care. Methods Multilevel logistic regression models were developed, using individual participant data from seven primary care-based studies (n=1244), to predict relapse of depression. The model was internally validated using bootstrapping, and generalisability was explored using internal–external cross-validation. Findings Residual depressive symptoms (OR: 1.13 (95% CI: 1.07 to 1.20), pConclusions We could not predict risk of depression relapse with sufficient accuracy in primary care data, using routinely recorded measures. Relationship status warrants further research to explore its role as a prognostic factor for relapse. Clinical implications Until we can accurately stratify patients according to risk of relapse, a universal approach to relapse prevention may be most beneficial, either during acute-phase treatment or post remission. Where possible, this could be guided by the presence or absence of known prognostic factors (eg, residual depressive symptoms) and targeted towards these. Trial registration number NCT04666662.
- Open Access
- 20 September 2024
- Published by Royal College of General Practitioners in British Journal of General Practice
- Vol. 75 (753) , e292-e299
Role of primary care in depression relapse: a qualitative study
Background: Relapse contributes to the clinical and societal burden associated with depression. It is not well understood how relapse risk and prevention are managed and discussed between patients and GPs in primary care. Aim: To understand the extent to which relapse risk and prevention are discussed and managed in general practice. Design and setting: A qualitative study undertaken in general practice in the UK. Method: Participants were recruited through general practices. Data were generated using semi-structured interviews and analysed using thematic analysis. Patient and public involvement informed all aspects of the study. Results: Twenty-three people with lived experience of depression and 22 GPs were interviewed. The following three themes are presented in this paper: perceived determinants of depression course (participants viewed environmental, social, and personal factors as being most important); relapse risk and prevention (relapse was considered important but not consistently or routinely discussed in general practice consultations); and relationships and communication (participants discussed the key role of the GP–patient relationship). Conceptually, relapse was perceived as having limited meaning and usefulness in primary care, owing to the implication of an episodic, discrete course not recognised by many patients and an over-reliance on biomedical diagnosis. Longer-term follow-up and monitoring of depression could be improved in primary care. Conclusion: We provide an evidence-informed framework to improve practice systems and GP consultations to enhance longer-term care and support for people with depression. Going forwards, acute depression management could be optimised to include discussions of relapse risk and prevention. Brief, scalable relapse prevention interventions are needed for use in primary care.
- 20 September 2024
- Published by Royal College of General Practitioners in British Journal of General Practice
- Vol. 75 (753) , e292-e299
Open AccessRole of primary care in depression relapse: a qualitative study
Background: Relapse contributes to the clinical and societal burden associated with depression. It is not well understood how relapse risk and prevention are managed and discussed between patients and GPs in primary care. Aim: To understand the extent to which relapse risk and prevention are discussed and managed in general practice. Design and setting: A qualitative study undertaken in general practice in the UK. Method: Participants were recruited through general practices. Data were generated using semi-structured interviews and analysed using thematic analysis. Patient and public involvement informed all aspects of the study. Results: Twenty-three people with lived experience of depression and 22 GPs were interviewed. The following three themes are presented in this paper: perceived determinants of depression course (participants viewed environmental, social, and personal factors as being most important); relapse risk and prevention (relapse was considered important but not consistently or routinely discussed in general practice consultations); and relationships and communication (participants discussed the key role of the GP–patient relationship). Conceptually, relapse was perceived as having limited meaning and usefulness in primary care, owing to the implication of an episodic, discrete course not recognised by many patients and an over-reliance on biomedical diagnosis. Longer-term follow-up and monitoring of depression could be improved in primary care. Conclusion: We provide an evidence-informed framework to improve practice systems and GP consultations to enhance longer-term care and support for people with depression. Going forwards, acute depression management could be optimised to include discussions of relapse risk and prevention. Brief, scalable relapse prevention interventions are needed for use in primary care.
- Open Access
- 1 August 2024
- Published by National Institute for Health and Care Research in Health Technology Assessment
- Vol. 28 (39) , 1-121
Impact of Social Stories on social and emotional health of autism spectrum primary school children: the ASSSIST2 RCT with economic evaluation
Background: Differences in the way autistic children experience the world can contribute to anxiety and stress. Carol Gray’s Social Stories™ are a highly personalised intervention to support children by providing social information about specific situations in an individual story. Objectives: This randomised controlled trial aimed to establish whether Social Stories are clinically effective and cost-effective in improving social responsiveness and social and emotional health in children on the autism spectrum in schools. Design: A multisite pragmatic cluster randomised controlled trial comparing Social Stories with care as usual. Setting: Eighty-seven schools (clusters) across Yorkshire and the Humber. Participants: Two hundred and forty-nine children were randomised via a bespoke system hosted at York Trials Unit (129 Social Stories and 120 care as usual). Recruitment was completed in May 2021. Participants were children aged 4–11 years with a diagnosis of autism, alongside teachers, interventionists and caregivers. Recruitment was via schools, NHS trusts, support groups and local publicity. Intervention: The intervention included training for educational professionals and caregivers covering psychoeducation and implementation of Social Stories. Stories were written around contextualised goals around the child’s need for social information. Interventionists read the Social Story™ with the child at least six times over 4 weeks during school. Main outcome measure: The primary outcome was the Social Responsiveness Scale-2 completed by teachers at 6 months (the primary end point), which measures social awareness, cognition, communication and behaviour. Data were collected from caregivers and educational professionals at 6 weeks and 6 months through questionnaires. Blinding of participants was not possible. Results: At 6 months, the estimated difference in expected teacher-reported Social Responsiveness Scale-2 T-score (the primary end point) was −1.61 (95% confidence interval −4.18 to 0.96, p = 0.220), slightly favouring the intervention group. The estimated differences for the parent-reported secondary outcomes at 6 months were small and generally favoured the control group except the measure of children’s quality-adjusted life-year (+ 0.001, 95% confidence interval −0.032 to 0.035) and parental stress (−1.49, 95% confidence interval −5.43 to 2.46, p = 0.460), which favoured the intervention group. Children in the intervention group met their individual goals more frequently than children who received usual care alone (0.97 confidence interval 0.21 to 1.73, p = 0.012). The intervention is likely to save small costs (−£191 per child, 95% confidence interval −767.7 to 337.7) and maintain a similar quality of life compared to usual care. The probability of Social Stories being a preferred option is 75% if the society is willing to pay £20,000 per quality-adjusted life-year gained. Limitations include considerable disruptions during the coronavirus disease 2019 pandemic. Conclusion: Social Stories are used in schools and represent a low-cost intervention. There is no clinically evident impact on social responsiveness, anxiety and/or depression, parental stress or general health. Benefits were observed for specific behavioural goals as assessed by the teacher, and Social Stories may serve as a useful tool for facilitating dialogue between children and school staff to address specific behavioural challenges. Usage should be at the school’s discretion. Future work: Given the uncertainty of the results in light of coronavirus disease 2019, further work to establish the impact of Social Stories is merited. Trial registration: This trial is registered as ISRCTN11634810. Funding: This award was funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme (NIHR award ref: 16/111/91) and is published in full in Health Technology Assessment; Vol. 28, No. 39. See the NIHR Funding and Awards website for further award information.
- 1 August 2024
- Published by National Institute for Health and Care Research in Health Technology Assessment
- Vol. 28 (39) , 1-121
Open AccessImpact of Social Stories on social and emotional health of autism spectrum primary school children: the ASSSIST2 RCT with economic evaluation
Background: Differences in the way autistic children experience the world can contribute to anxiety and stress. Carol Gray’s Social Stories™ are a highly personalised intervention to support children by providing social information about specific situations in an individual story. Objectives: This randomised controlled trial aimed to establish whether Social Stories are clinically effective and cost-effective in improving social responsiveness and social and emotional health in children on the autism spectrum in schools. Design: A multisite pragmatic cluster randomised controlled trial comparing Social Stories with care as usual. Setting: Eighty-seven schools (clusters) across Yorkshire and the Humber. Participants: Two hundred and forty-nine children were randomised via a bespoke system hosted at York Trials Unit (129 Social Stories and 120 care as usual). Recruitment was completed in May 2021. Participants were children aged 4–11 years with a diagnosis of autism, alongside teachers, interventionists and caregivers. Recruitment was via schools, NHS trusts, support groups and local publicity. Intervention: The intervention included training for educational professionals and caregivers covering psychoeducation and implementation of Social Stories. Stories were written around contextualised goals around the child’s need for social information. Interventionists read the Social Story™ with the child at least six times over 4 weeks during school. Main outcome measure: The primary outcome was the Social Responsiveness Scale-2 completed by teachers at 6 months (the primary end point), which measures social awareness, cognition, communication and behaviour. Data were collected from caregivers and educational professionals at 6 weeks and 6 months through questionnaires. Blinding of participants was not possible. Results: At 6 months, the estimated difference in expected teacher-reported Social Responsiveness Scale-2 T-score (the primary end point) was −1.61 (95% confidence interval −4.18 to 0.96, p = 0.220), slightly favouring the intervention group. The estimated differences for the parent-reported secondary outcomes at 6 months were small and generally favoured the control group except the measure of children’s quality-adjusted life-year (+ 0.001, 95% confidence interval −0.032 to 0.035) and parental stress (−1.49, 95% confidence interval −5.43 to 2.46, p = 0.460), which favoured the intervention group. Children in the intervention group met their individual goals more frequently than children who received usual care alone (0.97 confidence interval 0.21 to 1.73, p = 0.012). The intervention is likely to save small costs (−£191 per child, 95% confidence interval −767.7 to 337.7) and maintain a similar quality of life compared to usual care. The probability of Social Stories being a preferred option is 75% if the society is willing to pay £20,000 per quality-adjusted life-year gained. Limitations include considerable disruptions during the coronavirus disease 2019 pandemic. Conclusion: Social Stories are used in schools and represent a low-cost intervention. There is no clinically evident impact on social responsiveness, anxiety and/or depression, parental stress or general health. Benefits were observed for specific behavioural goals as assessed by the teacher, and Social Stories may serve as a useful tool for facilitating dialogue between children and school staff to address specific behavioural challenges. Usage should be at the school’s discretion. Future work: Given the uncertainty of the results in light of coronavirus disease 2019, further work to establish the impact of Social Stories is merited. Trial registration: This trial is registered as ISRCTN11634810. Funding: This award was funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme (NIHR award ref: 16/111/91) and is published in full in Health Technology Assessment; Vol. 28, No. 39. See the NIHR Funding and Awards website for further award information.
- Open Access
The development and validation of a prognostic model to predict relapse in adults with remitted depression in primary care: secondary analysis of pooled individual participant data from multiple studies
Background Relapse of depression is common and contributes to the overall associated morbidity and burden. We lack evidence-based tools to estimate an individual’s risk of relapse after treatment in primary care, which may help us more effectively target relapse prevention. Objective Develop and validate a prognostic model to predict risk of relapse of depression in primary care. Methods Multilevel logistic regression models were developed, using individual participant data from seven primary care-based studies (n=1244), to predict relapse of depression. The model was internally validated using bootstrapping and generalisability was explored using internal-external cross-validation. Findings Residual depressive symptoms [Odds ratio (OR): 1.13 (95% CI: 1.07-1.20), pConclusions We cannot currently predict risk of depression relapse with sufficient accuracy in a primary care setting, using routinely recorded measures. Relationship status warrants further research to explore its role as a prognostic factor for relapse. Clinical implications Until we can accurately stratify patients according to risk of relapse, a universal approach to relapse prevention may be most beneficial, either during acute phase treatment or post-remission. Where possible, this could be guided by the presence or absence of known prognostic factors (e.g. residual depressive symptoms) and targeted towards these. What is already known on this topic Relapse contributes to the morbidity and burden associated with depression and, while there is robust research confirming predictors of relapse, individualised risk prediction is a challenge. What this study adds We found that it is not possible to accurately predict individualised risk of relapse using prognostic factors that are routinely collected and available in primary care. We found evidence to suggest that relationship status (not being in a relationship) is associated with increased risk of relapse and warrants confirmatory prognostic factor research. How this study might affect research, practice or policy Future prognosis research in this area should focus on exploring the feasibility of routinely measuring and documenting additional prognostic factors in primary care (for example, adverse childhood events, relationship status and social support) and including these in prognostic models. Until we can more accurately identify individuals at increased risk of relapse, commonly used acute-phase treatments could be optimised to better prepare for and mitigate the risk of relapse and there is a need for brief, scalable relapse prevention interventions that could be provided more widely.
Open AccessThe development and validation of a prognostic model to predict relapse in adults with remitted depression in primary care: secondary analysis of pooled individual participant data from multiple studies
Background Relapse of depression is common and contributes to the overall associated morbidity and burden. We lack evidence-based tools to estimate an individual’s risk of relapse after treatment in primary care, which may help us more effectively target relapse prevention. Objective Develop and validate a prognostic model to predict risk of relapse of depression in primary care. Methods Multilevel logistic regression models were developed, using individual participant data from seven primary care-based studies (n=1244), to predict relapse of depression. The model was internally validated using bootstrapping and generalisability was explored using internal-external cross-validation. Findings Residual depressive symptoms [Odds ratio (OR): 1.13 (95% CI: 1.07-1.20), pConclusions We cannot currently predict risk of depression relapse with sufficient accuracy in a primary care setting, using routinely recorded measures. Relationship status warrants further research to explore its role as a prognostic factor for relapse. Clinical implications Until we can accurately stratify patients according to risk of relapse, a universal approach to relapse prevention may be most beneficial, either during acute phase treatment or post-remission. Where possible, this could be guided by the presence or absence of known prognostic factors (e.g. residual depressive symptoms) and targeted towards these. What is already known on this topic Relapse contributes to the morbidity and burden associated with depression and, while there is robust research confirming predictors of relapse, individualised risk prediction is a challenge. What this study adds We found that it is not possible to accurately predict individualised risk of relapse using prognostic factors that are routinely collected and available in primary care. We found evidence to suggest that relationship status (not being in a relationship) is associated with increased risk of relapse and warrants confirmatory prognostic factor research. How this study might affect research, practice or policy Future prognosis research in this area should focus on exploring the feasibility of routinely measuring and documenting additional prognostic factors in primary care (for example, adverse childhood events, relationship status and social support) and including these in prognostic models. Until we can more accurately identify individuals at increased risk of relapse, commonly used acute-phase treatments could be optimised to better prepare for and mitigate the risk of relapse and there is a need for brief, scalable relapse prevention interventions that could be provided more widely.
- Open Access
Multimorbidity in Older Adults with Depression Study (MODS) (Behavioural Activation to improve physical and mental functioning among older people with multiple long-term conditions): Protocol for a fully powered randomised controlled trial
Introduction: Older adults (65 years or over) and those with long-term health conditions (LTCs), represent a ‘high risk’ group for depression, with a risk two-to-three times the general population. This can lead to poorer quality of life and be costly to health and social care services. In the Multimorbidity in Older Adults with Depression Study (MODS) we will test whether a brief psychological intervention (Behavioural Activation), helps to improve physical/mental functioning in this group compared to treatment as usual. Methods: We will conduct a two-arm, parallel-group randomised controlled trial, to evaluate the clinical and cost-effectiveness of the MODS intervention. Participants will be recruited via general practices across England. To be included, participants must be aged 65 years or over, with two or more LTCs and either sub-threshold depression or major depression. Randomisation will be simple 1:1. Intervention participants will receive up to eight sessions delivered by MODS support workers, supported by a self-help booklet. Control participants will receive usual care. A process evaluation will be undertaken to evaluate the processes and mechanisms underpinning intervention delivery, and to inform the development of an implementation framework. Semi-structured interviews will be conducted with intervention participants, participant’s caregivers/supportive others, and health and social care professionals. Focus groups and semi-structured interviews will be conducted with MODS support workers. Outcome data will be collected at four, eight, and twelve-months post-randomisation. The primary outcome is self-reported quality of life and functioning at the four-month follow up. Secondary outcomes include depression, anxiety, physical functioning, loneliness, social isolation, chronic pain, health related quality of life, and health services use. Discussion: This study builds on our previous work and will evaluate a brief psychological intervention to improve physical and mental health functioning for older adults with multiple long-term conditions. Trial Registration: ClinicalTrials.Gov Identifier ISRCTN44184899 , registered on 11 th August 2022.
Open AccessMultimorbidity in Older Adults with Depression Study (MODS) (Behavioural Activation to improve physical and mental functioning among older people with multiple long-term conditions): Protocol for a fully powered randomised controlled trial
Introduction: Older adults (65 years or over) and those with long-term health conditions (LTCs), represent a ‘high risk’ group for depression, with a risk two-to-three times the general population. This can lead to poorer quality of life and be costly to health and social care services. In the Multimorbidity in Older Adults with Depression Study (MODS) we will test whether a brief psychological intervention (Behavioural Activation), helps to improve physical/mental functioning in this group compared to treatment as usual. Methods: We will conduct a two-arm, parallel-group randomised controlled trial, to evaluate the clinical and cost-effectiveness of the MODS intervention. Participants will be recruited via general practices across England. To be included, participants must be aged 65 years or over, with two or more LTCs and either sub-threshold depression or major depression. Randomisation will be simple 1:1. Intervention participants will receive up to eight sessions delivered by MODS support workers, supported by a self-help booklet. Control participants will receive usual care. A process evaluation will be undertaken to evaluate the processes and mechanisms underpinning intervention delivery, and to inform the development of an implementation framework. Semi-structured interviews will be conducted with intervention participants, participant’s caregivers/supportive others, and health and social care professionals. Focus groups and semi-structured interviews will be conducted with MODS support workers. Outcome data will be collected at four, eight, and twelve-months post-randomisation. The primary outcome is self-reported quality of life and functioning at the four-month follow up. Secondary outcomes include depression, anxiety, physical functioning, loneliness, social isolation, chronic pain, health related quality of life, and health services use. Discussion: This study builds on our previous work and will evaluate a brief psychological intervention to improve physical and mental health functioning for older adults with multiple long-term conditions. Trial Registration: ClinicalTrials.Gov Identifier ISRCTN44184899 , registered on 11 th August 2022.
- Open Access
Mitigating the psychological impacts of COVID-19 restrictions on older people: The UK Behavioural Activation in Social Isolation (BASIL+) COVID-19 Urgent Public Health (UPH) trial and living systematic review
Background Older adults were more likely to be socially isolated during the COVID-19 pandemic, with risk of depression and loneliness. Behavioural Activation (BA) could feasibly maintain mental health in the face of COVID isolation. Methods We undertook a multicentre randomised controlled trial [BASIL+ ISRCTN63034289] of BA to mitigate depression and loneliness among older people. BA was offered by telephone to intervention participants (n=218). Control participants received usual care, with existing COVID wellbeing resources (n=217). Findings Participants engaged with 5.2 (SD 2.9) of 8 remote BA sessions. Adjusted mean difference (AMD) for depression (PHQ-9) at 3 months [primary outcome] was -1.65 (95% CI -2.54 to -0.75, pInterpretation BA is an effective intervention that reduces depression and some aspects of loneliness in the short term. This adds to the range of strategies to improve population mental health, particularly among older adults with multiple long-term conditions. These results will be helpful to policy makers in preventing depression and loneliness beyond the pandemic. Funding NIHR RP-PG-0217-20006
Open AccessMitigating the psychological impacts of COVID-19 restrictions on older people: The UK Behavioural Activation in Social Isolation (BASIL+) COVID-19 Urgent Public Health (UPH) trial and living systematic review
Background Older adults were more likely to be socially isolated during the COVID-19 pandemic, with risk of depression and loneliness. Behavioural Activation (BA) could feasibly maintain mental health in the face of COVID isolation. Methods We undertook a multicentre randomised controlled trial [BASIL+ ISRCTN63034289] of BA to mitigate depression and loneliness among older people. BA was offered by telephone to intervention participants (n=218). Control participants received usual care, with existing COVID wellbeing resources (n=217). Findings Participants engaged with 5.2 (SD 2.9) of 8 remote BA sessions. Adjusted mean difference (AMD) for depression (PHQ-9) at 3 months [primary outcome] was -1.65 (95% CI -2.54 to -0.75, pInterpretation BA is an effective intervention that reduces depression and some aspects of loneliness in the short term. This adds to the range of strategies to improve population mental health, particularly among older adults with multiple long-term conditions. These results will be helpful to policy makers in preventing depression and loneliness beyond the pandemic. Funding NIHR RP-PG-0217-20006
- Open Access
- 1 February 2023
- Published by National Institute for Health and Care Research in Health Technology Assessment
- Vol. 27 (2) , 1-226
Routinely used interventions to improve attachment in infants and young children: a national survey and two systematic reviews
Background: Attachment refers to an infant’s innate tendency to seek comfort from their caregiver. Research shows that attachment is important in promoting healthy social and emotional development. Many parenting interventions have been developed to improve attachment outcomes for children. However, numerous interventions used in routine practice have a limited evidence base, meaning that we cannot be sure if they are helpful or harmful. Objectives: This research aimed to conduct a large-scale survey to identify what interventions are being used in UK services to improve child attachment; conduct a systematic review to evaluate the evidence for parenting attachment interventions; and develop recommendations for future research and practice. Design and methods: We worked closely with our Expert Reference Group to plan a large-scale survey focused on relevant UK services. We then conducted two systematic reviews. One searched for all randomised controlled trial evidence for any attachment parenting intervention. The second searched for all research for the top 10 routinely used interventions identified from the survey. Results: The survey collected 625 responses covering 734 UK services. The results identified the 10 most commonly used interventions. The responses showed a limited use of validated measures and a wide variety of definitions of attachment. For the first review, seven studies were included from 2516 identified records. These were combined with results from previous reviews conducted by the team. Meta-analyses showed that, overall, parenting interventions are effective in reducing disorganised attachment (pooled odds ratio 0.54, 95% confidence interval 0.39 to 0.77) and increasing secure attachment (pooled odds ratio 1.85, 95% confidence interval 1.36 to 2.52). The second review searched the literature for the top 10 routinely used interventions identified by the survey; 61 studies were included from 1198 identified records. The results showed that many of the most commonly used interventions in UK services have a weak evidence base and those with the strongest evidence base are not as widely used. Conclusions: There is a need for better links between research and practice to ensure that interventions offered to families are safe and effective. Possible reasons for the disparity include the cost and accessibility of training. There is also a need for improved understanding by professionals regarding the meaning of attachment. Limitations: Although the survey had good geographical spread, most respondents were based in England. For review 2 we were unable to access a large number of papers; however, we conducted extensive reference checking to account for this. Future work: There is a need for robust research to test the efficacy of routinely used attachment interventions. Research could also explore why routinely used interventions are not consistently subject to thorough evaluation; how to embed dissemination, cost-effectiveness, fidelity and sustainability into research; and how to keep clinical practice up to date with research developments. Study registration: This study is registered as PROSPERO CRD42019137362. Funding: This project was funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 27, No. 2. See the NIHR Journals Library website for further project information.
- 1 February 2023
- Published by National Institute for Health and Care Research in Health Technology Assessment
- Vol. 27 (2) , 1-226
Open AccessRoutinely used interventions to improve attachment in infants and young children: a national survey and two systematic reviews
Background: Attachment refers to an infant’s innate tendency to seek comfort from their caregiver. Research shows that attachment is important in promoting healthy social and emotional development. Many parenting interventions have been developed to improve attachment outcomes for children. However, numerous interventions used in routine practice have a limited evidence base, meaning that we cannot be sure if they are helpful or harmful. Objectives: This research aimed to conduct a large-scale survey to identify what interventions are being used in UK services to improve child attachment; conduct a systematic review to evaluate the evidence for parenting attachment interventions; and develop recommendations for future research and practice. Design and methods: We worked closely with our Expert Reference Group to plan a large-scale survey focused on relevant UK services. We then conducted two systematic reviews. One searched for all randomised controlled trial evidence for any attachment parenting intervention. The second searched for all research for the top 10 routinely used interventions identified from the survey. Results: The survey collected 625 responses covering 734 UK services. The results identified the 10 most commonly used interventions. The responses showed a limited use of validated measures and a wide variety of definitions of attachment. For the first review, seven studies were included from 2516 identified records. These were combined with results from previous reviews conducted by the team. Meta-analyses showed that, overall, parenting interventions are effective in reducing disorganised attachment (pooled odds ratio 0.54, 95% confidence interval 0.39 to 0.77) and increasing secure attachment (pooled odds ratio 1.85, 95% confidence interval 1.36 to 2.52). The second review searched the literature for the top 10 routinely used interventions identified by the survey; 61 studies were included from 1198 identified records. The results showed that many of the most commonly used interventions in UK services have a weak evidence base and those with the strongest evidence base are not as widely used. Conclusions: There is a need for better links between research and practice to ensure that interventions offered to families are safe and effective. Possible reasons for the disparity include the cost and accessibility of training. There is also a need for improved understanding by professionals regarding the meaning of attachment. Limitations: Although the survey had good geographical spread, most respondents were based in England. For review 2 we were unable to access a large number of papers; however, we conducted extensive reference checking to account for this. Future work: There is a need for robust research to test the efficacy of routinely used attachment interventions. Research could also explore why routinely used interventions are not consistently subject to thorough evaluation; how to embed dissemination, cost-effectiveness, fidelity and sustainability into research; and how to keep clinical practice up to date with research developments. Study registration: This study is registered as PROSPERO CRD42019137362. Funding: This project was funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 27, No. 2. See the NIHR Journals Library website for further project information.